• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human PB CD8+ T Cells

  • For research use only

Cat No.

ABC-TC4005

Product Type

Immune Cells

Cell Type

T Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Storage

Liquid Nitrogen

NPB-CD8+ Cytotoxic T cells are negatively isolated from Mononuclear Cells using an indirect immunomagnetic CD8+ T cell labeling system.

Product Image

Description

Human Peripheral Blood CD8+ T Cells are isolated from mononuclear cells. After primary culture, these cells are cryopreserved in optimal conditions to maintain viability and function upon thawing. CD8+ T cells, also known as cytotoxic T lymphocytes, play a critical role in adaptive immunity by recognizing and eliminating infected or malignant cells through MHC class I-restricted antigen presentation. They are essential for studying T cell-mediated cytotoxicity, immune checkpoint regulation, antiviral responses, and tumor immunology. In vitro, these Human PB CD8+ T Cells display limited proliferative capacity. Repeated freeze-thaw cycles should be avoided to preserve functionality. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human PB CD8+ T Cells, Peripheral CD8+ T Lymphocytes, PB Cytotoxic T Cells, CD8+ CTLs

Species

Human

Cat.No

ABC-TC4005

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

T Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human PB CD8+ T Cells can be used as an in vitro model to study adaptive immune responses, including cytotoxic activity against virus-infected or cancerous cells. These cells help elucidate the mechanisms of T cell activation, differentiation, and effector function. They can also be applied in immunotherapy development, vaccine evaluation, and immune profiling. Investigating CD8+ T cells can also provide insight into autoimmune responses and chronic inflammatory conditions, supporting therapeutic target discovery in infectious diseases and cancer immunology.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human PB CD8+ T Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button